Bifogade filer
Prenumeration
Kalender
Tid* | ||
2025-08-06 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-07 | 08:00 | Kvartalsrapport 2025-Q1 |
2025-02-12 | 08:00 | Bokslutskommuniké 2024 |
2024-11-06 | - | Kvartalsrapport 2024-Q3 |
2024-08-07 | - | Kvartalsrapport 2024-Q2 |
2024-05-22 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2024-05-21 | - | Årsstämma |
2024-05-08 | - | Kvartalsrapport 2024-Q1 |
2024-02-14 | - | Bokslutskommuniké 2023 |
2023-11-08 | - | Kvartalsrapport 2023-Q3 |
2023-08-02 | - | Kvartalsrapport 2023-Q2 |
2023-05-25 | - | Extra Bolagsstämma 2023 |
2023-05-16 | - | Årsstämma |
2023-05-05 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2023-05-04 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-09 | - | Kvartalsrapport 2022-Q3 |
2022-08-05 | - | Kvartalsrapport 2022-Q2 |
2022-05-20 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2022-05-19 | - | Årsstämma |
2022-05-06 | - | Kvartalsrapport 2022-Q1 |
2022-02-18 | - | Bokslutskommuniké 2021 |
2021-10-26 | - | Kvartalsrapport 2021-Q3 |
2021-08-06 | - | Kvartalsrapport 2021-Q2 |
2021-05-21 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2021-05-20 | - | Årsstämma |
2021-05-06 | - | Kvartalsrapport 2021-Q1 |
2021-02-25 | - | Bokslutskommuniké 2020 |
2020-11-20 | - | Kvartalsrapport 2020-Q3 |
2020-07-31 | - | Kvartalsrapport 2020-Q2 |
2020-05-15 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2020-05-14 | - | Årsstämma |
2020-05-14 | - | Kvartalsrapport 2020-Q1 |
2020-03-26 | - | Extra Bolagsstämma 2020 |
2020-02-28 | - | Bokslutskommuniké 2019 |
2019-11-14 | - | Kvartalsrapport 2019-Q3 |
2019-08-29 | - | Kvartalsrapport 2019-Q2 |
2019-05-23 | - | Årsstämma |
2019-05-17 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2019-05-16 | - | Kvartalsrapport 2019-Q1 |
2019-02-14 | - | Bokslutskommuniké 2018 |
2018-11-28 | - | Kvartalsrapport 2018-Q3 |
2018-08-24 | - | Kvartalsrapport 2018-Q2 |
2018-05-16 | - | X-dag ordinarie utdelning XSPRAY 0.00 SEK |
2018-05-14 | - | Årsstämma |
2018-05-14 | - | Kvartalsrapport 2018-Q1 |
2018-02-20 | - | Extra Bolagsstämma 2017 |
2018-02-19 | - | Bokslutskommuniké 2017 |
2017-11-22 | - | Kvartalsrapport 2017-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Bioteknik |
Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) today announces that the number of shares and votes in Xspray Pharma AB has changed. New shares have been issued and registered through the subscription of warrants series TO6 2023, which ended on May 2, 2024. In total, the number of outstanding shares and votes has increased by 2,508,723.
The number of shares has increased by 2,508,723 from 31,253,542 to 33,762,265. The share capital has increased by SEK 2,508,723, from SEK 31,253,542 to SEK 33,762,265.
For further information, please contact:
Kerstin Hasselgren
Senior Advisor & Investor Relations
Xspray Pharma AB
Mob: +46 (0) 70 311 16 83
E-mail: kerstin.hasselgren@xspray.com
About Xspray Pharma
About Xspray Pharma AB
Xspray Pharma AB (publ) is a pharmaceutical company focused on the development of improved PKIs for cancer treatment, leveraging its proprietary HyNap™ technology platform. The company aims to enhance clinical outcomes for cancer patients by improving the efficacy, safety, and patient experience of existing cancer therapies. Xspray Pharma’s shares are traded at Nasdaq Stockholm (Nasdaq Stockholm: XSPRAY). For more information about Xspray Pharma AB and its innovative approach to cancer treatment, please visit www.xspraypharma.com.
This information is information that Xspray Pharma AB is obliged to make public pursuant to the Financial Instruments Trading Act. The information was submitted for publication at 2024-05-31 17:30 CEST.